Current
$31.5B
5-Year Average
$33.1B
All-Time High
$43.6B
All-Time Low
$839M
Market cap daily chart for ResMed (RMD)
Aug 2, 2021 – Jul 29, 2026 · 1,253 trading days
Market Cap growth chart for ResMed (RMD) from 2017 to 2026
Latest: -17.1%
Market Cap history table for ResMed (RMD) from 1995 to 2026
| 2026 | $31.5B | -17.1% | -$6.51B | ||
| 2025 | $38B | +34.6% | +$9.77B | ||
| 2024 | $28.2B | -12.3% | -$3.97B | ||
| 2023 | $32.2B | +4.5% | +$1.39B | ||
| 2022 | $30.8B | -14.6% | -$5.28B | ||
| 2021 | $36.1B | +29.1% | +$8.14B | ||
| 2020 | $28B | +58.6% | +$10.3B | ||
| 2019 | $17.6B | +18.2% | +$2.72B | ||
| 2018 | $14.9B | +34.4% | +$3.82B | ||
| 2017 | $11.1B | +23.8% | +$2.14B | ||
| 2016 | $8.96B | +11.4% | +$914M | ||
| 2015 | $8.04B | +10.0% | +$734M | ||
| 2014 | $7.31B | +10.6% | +$701M | ||
| 2013 | $6.61B | +41.8% | +$1.95B | ||
| 2012 | $4.66B | -4.2% | -$207M | ||
| 2011 | $4.87B | +3.2% | +$149M | ||
| 2010 | $4.72B | +50.2% | +$1.58B | ||
| 2009 | $3.14B | +11.6% | +$327M | ||
| 2008 | $2.81B | -12.9% | -$416M | ||
| 2007 | $3.23B | -10.9% | -$395M | ||
| 2006 | $3.62B | +46.5% | +$1.15B | ||
| 2005 | $2.47B | +38.2% | +$683M | ||
| 2004 | $1.79B | +32.6% | +$440M | ||
| 2003 | $1.35B | +34.7% | +$348M | ||
| 2002 | $1B | -40.8% | -$691M | ||
| 2001 | $1.69B | +95.8% | +$829M | ||
| 2000 | $864M | +67.6% | +$349M | ||
| 1999 | $516M | +50.4% | +$173M | ||
| 1998 | $343M | +92.7% | +$165M | ||
| 1997 | $178M | +63.3% | +$69M | ||
| 1996 | $109M | +107.6% | +$56.5M | ||
| 1995 | $52.5M | — | — |
- 2026$31.5B-17.1%
- 2025$38B+34.6%
- 2024$28.2B-12.3%
- 2023$32.2B+4.5%
- 2022$30.8B-14.6%
- 2021$36.1B+29.1%
- 2020$28B+58.6%
- 2019$17.6B+18.2%
- 2018$14.9B+34.4%
- 2017$11.1B+23.8%
- 2016$8.96B+11.4%
- 2015$8.04B+10.0%
- 2014$7.31B+10.6%
- 2013$6.61B+41.8%
- 2012$4.66B-4.2%
- 2011$4.87B+3.2%
- 2010$4.72B+50.2%
- 2009$3.14B+11.6%
- 2008$2.81B-12.9%
- 2007$3.23B-10.9%
- 2006$3.62B+46.5%
- 2005$2.47B+38.2%
- 2004$1.79B+32.6%
- 2003$1.35B+34.7%
- 2002$1B-40.8%
- 2001$1.69B+95.8%
- 2000$864M+67.6%
- 1999$516M+50.4%
- 1998$343M+92.7%
- 1997$178M+63.3%
- 1996$109M+107.6%
- 1995$52.5M—
Market Cap values are taken from ResMed's reported income statements (share counts) and end-of-day prices (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Market Cap at ResMed (RMD)
According to ResMed's latest reported financial statements, the company's latest reported market cap is $33B. Market capitalization is the total dollar value of all outstanding shares — shares outstanding × stock price — and the standard measure of a company's equity value. On this page, historical market cap snaps filing-period share counts to closing prices on or before each statement date (not intraday tick data).
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
ResMed (RMD) most recent annual market cap stands at $31.5B (2026) – declined 17.1% year-over-year.
Over 2021–2026 (5 years), ResMed market cap expanded at a -2.7% compound annual rate, with a net decline across the window.
ResMed market cap peaked at $38B in 2025; the latest annual figure is $31.5B in 2026 (17.1% below peak).
The record annual market cap stands at $38B, reached in 2025; the historical low of $52.5M was recorded in 1995.
ResMed Market Cap by Year
ResMed Market Cap 2026: $31.5B
2026's market cap for ResMed came in at $31.5B, declined 17.1% below 2025.
ResMed Market Cap 2025: $38B
ResMed posted market cap of $38B in 2025, surged 34.6% from 2024. This figure represents the highest annual value in the available history.
ResMed Market Cap 2024: $28.2B
In 2024, ResMed reported market cap of $28.2B, declined 12.3% below 2023.
ResMed Market Cap 2023: $32.2B
ResMed market cap in 2023 was $32.2B, edged up 4.5% from 2022.
ResMed Market Cap 2022: $30.8B
ResMed market cap in 2022 was $30.8B.
See more financial history for ResMed (RMD).
Sector peers by Market Cap
Healthcare peers of ResMed (RMD), ranked by their latest market cap
| $1.14T | |
| $640B | |
| $466B | |
| $382B | |
| $322B | |
| $229B | |
| $214B | |
| $209B |
- $1.14T
- $466B
- $322B
- $229B
- $209B
Frequently asked questions
Test yourself on RMD
Market Cap — 10 rounds, every one of them RMD against another company. Leave whenever you like.
Practice run — it doesn’t move your skill rating and doesn’t touch the leaderboards. Misses do go into your review queue.
ResMed (RMD) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
- Buybacks1.82% TTM
- Dividend Profile1.12% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History4 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.